Signals, Powered By EquityPandit
An Establishment Inspection Report (EIR) has been received by the drug firm Strides Shasun from the US health regulator on closure of inspection of its oral dosage Facility at Bengaluru.
It has said in a BSE filing that “The company’s Oral Dosage Forms manufacturing site (KRS Gardens) in Bengaluru which was inspected by the USFDA in February 2016 has received the EIR, thereby confirming the closure of the inspection. The facility continues to be USFDA approved.”
